对接(动物)
生物信息学
虚拟筛选
计算生物学
Web服务器
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
2019年冠状病毒病(COVID-19)
结合亲和力
计算机科学
分子动力学
灵活性(工程)
蛋白质数据库
药物发现
结构生物信息学
结合位点
蛋白质结构
生物信息学
化学
生物
受体
互联网
计算化学
医学
生物化学
万维网
数学
传染病(医学专业)
疾病
护理部
病理
基因
统计
作者
Sarah Hall-Swan,Didier Devaurs,Maurício Rigo,Dinler Amaral Antunes,Lydia E. Kavraki,Geancarlo Zanatta
标识
DOI:10.1016/j.compbiomed.2021.104943
摘要
An unprecedented research effort has been undertaken in response to the ongoing COVID-19 pandemic. This has included the determination of hundreds of crystallographic structures of SARS-CoV-2 proteins, and numerous virtual screening projects searching large compound libraries for potential drug inhibitors. Unfortunately, these initiatives have had very limited success in producing effective inhibitors against SARS-CoV-2 proteins. A reason might be an often overlooked factor in these computational efforts: receptor flexibility. To address this issue we have implemented a computational tool for ensemble docking with SARS-CoV-2 proteins. We have extracted representative ensembles of protein conformations from the Protein Data Bank and from in silico molecular dynamics simulations. Twelve pre-computed ensembles of SARS-CoV-2 protein conformations have now been made available for ensemble docking via a user-friendly webserver called DINC-COVID (dinc-covid.kavrakilab.org). We have validated DINC-COVID using data on tested inhibitors of two SARS-CoV-2 proteins, obtaining good correlations between docking-derived binding energies and experimentally-determined binding affinities. Some of the best results have been obtained on a dataset of large ligands resolved via room temperature crystallography, and therefore capturing alternative receptor conformations. In addition, we have shown that the ensembles available in DINC-COVID capture different ranges of receptor flexibility, and that this diversity is useful in finding alternative binding modes of ligands. Overall, our work highlights the importance of accounting for receptor flexibility in docking studies, and provides a platform for the identification of new inhibitors against SARS-CoV-2 proteins.
科研通智能强力驱动
Strongly Powered by AbleSci AI